Evidence map›Paper›PMID 24884070›Full record

ArticleACS chemical neuroscience2014

Histamine H3 receptor activation counteracts adenosine A2A receptor-mediated enhancement of depolarization-evoked [3H]-GABA release from rat globus pallidus synaptosomes.

Guadalupe-Elide Morales-Figueroa, Ricardo Márquez-Gómez, Raúl González-Pantoja, Juan Escamilla-Sánchez, José-Antonio Arias-Montaño

Abstract read
In one paragraph

Article in ACS chemical neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Feedback facilitation by adenosine APurinergic signalling · 2024
    Article
  2. Adenosine APurinergic signalling · 2019
    Article
  3. Functional histamine HPharmacological research · 2018
    Article
  4. Article
  5. Adenosine AFrontiers in physiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Guadalupe-Elide Morales-FigueroaDepartamento de Fisiología, Biofísica y Neurociencias, Centro de Investigación y de Estudios Avanzados del IPN , Av. Instituto Politécnico Nacional 2508, Zacatenco, 07360 México, D.F., México.
Ricardo Márquez-Gómez
Raúl González-Pantoja
Juan Escamilla-Sánchez
José-Antonio Arias-Montaño
Instituto Politécnico Nacional · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High levels of histamine H3 receptors (H3Rs) are found in the globus pallidus (GP), a neuronal nucleus in the basal ganglia involved in the control of motor behavior. By using rat GP isolated nerve terminals (synaptosomes), we studied whether H3R activation modified the previously reported enhancing action of adenosine A2A receptor (A2AR) stimulation on depolarization-evoked [(3)H]-GABA release. At 3 and 10 nM, the A2AR agonist CGS-21680 enhanced [(3)H]-GABA release induced by high K(+) (20 mM) and the effect of 3 nM CGS-21680 was prevented by the A2AR antagonist ZM-241385 (100 nM). The presence of presynaptic H3Rs was confirmed by the specific binding of N-α-[methyl-(3)H]-histamine to membranes from GP synaptosomes (maximum binding, Bmax, 1327 ± 79 fmol/mg protein; dissociation constant, Kd, 0.74 nM), which was inhibited by the H3R ligands immepip, clobenpropit, and A-331440 (inhibition constants, Ki, 0.28, 8.53, and 316 nM, respectively). Perfusion of synaptosomes with the H3R agonist immepip (100 nM) had no effect on K(+)-evoked [(3)H]-GABA release, but inhibited the stimulatory action of A2AR activation. In turn, the effect of immepip was blocked by the H3R antagonist clobenpropit, which had no significant effect of its own on K(+)-induced [(3)H]-GABA release. These data indicate that H3R activation selectively counteracts the facilitatory action of A2AR stimulation on GABA release from striato-pallidal projections.

Indexed as

AdenosineAdenosine A2 Receptor AgonistsAdenosine A2 Receptor AntagonistsAnimalsBiphenyl Compoundsgamma-Aminobutyric AcidGlobus PallidusHistamine AgonistsHistamine H3 AntagonistsImidazolesMaleMembrane PotentialsNitrilesPhenethylaminesPiperidinesPotassium2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine4-(1H-imidazol-4-ylmethyl)piperidine4'-(3-(3(R)-(dimethylamino)-pyrrolidin-1-yl)-propoxy)-biphenyl-4-carbonitrileAdenosineAdenosine A2 Receptor AgonistsAdenosine A2 Receptor AntagonistsBiphenyl Compoundsclobenpropitgamma-Aminobutyric AcidHistamine AgonistsHistamine H3 AntagonistsImidazolesNitrilesPhenethylaminesPiperidinesPotassiumPyrrolidinesReceptor, Adenosine A2AReceptors, Histamine H3ThioureaTriazinesTriazolesTritiumZM 241385

Identifiers

PMID24884070
PMCPMC4140591
OpenAlexW2087771995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.